Striving for Zero Defects: Use of Quality-by-Design Principles for Manufacturing Parenteral Packaging Components to Mitigate Risks of Drug Product Contamination

Register free: http://www.pharmtech.com/pt_w/design_principles

Event Overview:

Visible particles are a concern for the pharmaceutical industry. In the last few years, a quarter of all sterile injectable drug recalls were linked to particulate found in finished drugs. This poses a significant challenge to address quality requirements and to comply with regulatory authorities in various geo-regions. This webcast will focus on innovations in the manufacturing of parenteral packaging components to address the demanding needs for packaging sensitive drugs, such as biologics.

Topics of discussion will include:

• Common concerns in the pharmaceutical industry surrounding parenteral packaging

• A quality-by-design approach to manufacturing components to mitigate industry concerns that relate to particulates and silicone contamination

• Analytical tools utilized to ensure packaging integrity and product quality

• Advancements in products and processes to achieve best-in-class specifications, with a focus on 'zero-defects'

Key Learning Objectives:

Understand the risks that face the pharmaceutical industry today from a drug packaging perspective, and discuss strategies to mitigate these risks

Introduce a QbD approach to product manufacturing and product design for pharmaceutical components with a focus on particulate reduction

Review solutions for manufacturing high-quality packaging components to meet the needs of biologics and sensitive molecules

Speakers: Rahul Thakar, PhD, Technical Key Account Manager, Datwyler

Elke Geuzens, Technical Key Account Manager, Datwyler

Time and date: Part I: Tuesday, Apr. 7, 2020 at 10am EDT | 9am CDT | 3pm BST | 4pm CEST

On demand available after airing until Apr. 7, 2021

Sponsor: Datwyler

Register free: http://www.pharmtech.com/pt_w/design_principles